<DOC>
	<DOCNO>NCT00215579</DOCNO>
	<brief_summary>As many 75 percent patient schizophrenia difficulty take oral medication regular basis . This may lead worsen symptom . Clinicians commonly respond problem add adjunctive medication , despite absence systematic study support practice . It possible , however , many case , unstable course and/or unsatisfactory treatment response reflect incomplete adherence originally prescribe oral antipsychotic , rather need adjunctive medication . This study examine whether switch patient demonstrate unstable course and/or unsatisfactory clinical response long-acting injectable preparation primary antipsychotic may enhance medication adherence improve outcome .</brief_summary>
	<brief_title>Determining Effects Risperdal Consta Patients With Psychotic Disorders Incomplete Adherence</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Eligible patient male female Between 1865 year age meet DSMIV criterion schizophrenia schizoaffective disorder . The subject must , physician opinion , unstable course must treat oral antipsychotic . Pregnant breast feeding female exclude . Because fluoxetine know change plasma level CONSTA , subject take fluoxetine within two week start study exclude . Patients know hypersensitivity oral Risperdal exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>